• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Oct 13
8:00 am - 9:00 am EDT

Member Forum: Technology Solutions for PALS

Oct 13
6:00 pm - 7:00 pm EDT

Member Forum: Technology Solutions for PALS

Oct 15
9:00 am - 10:00 am EDT

Webinar: The Use of AI in ALS/MND

Oct 17
2:00 pm - 3:00 pm EDT

ALS Association Webinar: So, What’s Next? Understanding the Decisions along an ALS Journey

Oct 21
7:00 am - 8:30 am EDT

Member Roundtable: Defining Rights in the Genetics Era of ALS/MND

View Calendar

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Rosie Riley, USA

    Rosie Riley, USA

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Daniel Hare, USA

    Daniel Hare, USA

  • Susan Keldani, USA

    Susan Keldani, USA

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Torben Mikkelsen, Denmark

    Torben Mikkelsen, Denmark

  • Andrew Langat, Kenya

    Andrew Langat, Kenya

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Liam Dwyer, England

    Liam Dwyer, England

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Jean

    Jean
    jean

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Jean Waters, UK

    Jean Waters, UK

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Willi Klein, UK

    Willi Klein, UK

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • JP

    JP

  • Lee Millard, England

    Lee Millard, England

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Timmy, Belgium

    Timmy, Belgium

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Ali Var, Turkey

    Ali Var, Turkey

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • David Watson, Scotland

    David Watson, Scotland

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Purningam Jacob, India

    Purningam Jacob, India

  • Glen Elison, USA

    Glen Elison, USA

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login